Bohrer RA. It’s the Antigen Stupid:: A Risk/Reward Approach to the Problem of Orphan Drug Act Exclusivity for Monoclonal Antibody Therapeutics. stlr [Internet]. 2004 Feb. 15 [cited 2024 Apr. 23];5. Available from: https://journals.library.columbia.edu/index.php/stlr/article/view/3629